Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.19% |
| 3 | Financials | 12.33% |
| 4 | Consumer Staples | 10.22% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVSA
1276
Covista Inc
CVSA
$4.49B
| $10.1M | 0.01% |
+264,900
| New | +$9.88M |
|
1277
Hecla Mining
HL
$12.3B
| $10M | 0.01% |
1,969,200
+558,800
| +40% | +$3.1M |
|
|
SRT
1278
DELISTED
Startek Inc.
SRT
| $10M | 0.01% |
819,800
+185,500
| +29% | +$1.9M |
|
1279
Boyd Gaming
BYD
$6.09B
| $10M | 0.01% |
403,899
+286,899
| +245% | +$6.91M |
|
|
IIP
1280
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
| $9.98M | 0.01% |
2,720,620
+866,401
| +47% | +$3.18M |
|
1281
Ameris Bancorp
ABCB
$6.02B
| $9.95M | 0.01% |
206,383
-32,500
| -14% | -$1.49M |
|
1282
Element Solutions
ESI
$9.45B
| $9.93M | 0.01% |
783,172
+431,272
| +123% | +$5.64M |
|
1283
Mizuho Financial
MFG
$132B
| $9.9M | 0.01% |
2,697,000
-46,400
| -2% | -$168K |
|
1284
Compass Minerals
CMP
$1.1B
| $9.88M | 0.01% |
151,300
+60,800
| +67% | +$4.05M |
|
|
NYRT
1285
DELISTED
New York REIT, Inc.
NYRT
| $9.87M | 0.01% |
114,270
-15,320
| -12% | -$1.39M |
|
1286
LeMaitre Vascular
LMAT
$1.87B
| $9.82M | 0.01% |
314,600
+131,300
| +72% | +$3.79M |
|
|
HCOM
1287
DELISTED
Hawaiian Telcom Holdco, Inc
HCOM
| $9.82M | 0.01% |
392,900
+16,800
| +4% | +$418K |
|
1288
Virtu Financial
VIRT
$5.11B
| $9.77M | 0.01% |
553,500
+132,400
| +31% | +$2.16M |
|
1289
Old Second Bancorp
OSBC
$1.31B
| $9.75M | 0.01% |
844,200
+123,000
| +17% | +$1.43M |
|
1290
Pilgrim's Pride
PPC
$6.59B
| $9.75M | 0.01% |
444,800
-642,100
| -59% | -$15.3M |
|
1291
Kadant
KAI
$3.95B
| $9.73M | 0.01% |
129,400
+51,300
| +66% | +$3.58M |
|
1292
Televisa
TV
$1.54B
| $9.69M | 0.01% |
+397,600
| New | +$9.88M |
|
1293
Trupanion
TRUP
$1.35B
| $9.69M | 0.01% |
432,950
+154,250
| +55% | +$2.78M |
|
1294
CRH
CRH
$64.4B
| $9.67M | 0.01% |
272,700
-22,400
| -8% | -$805K |
|
1295
TIM SA
TIMB
$8.28B
| $9.65M | 0.01% |
651,900
+598,400
| +1,119% | +$9.23M |
|
1296
CoStar Group
CSGP
$13.1B
| $9.65M | 0.01% |
+365,980
| New | +$8.9M |
|
|
BIG
1297
DELISTED
Big Lots, Inc.
BIG
| $9.64M | 0.01% |
+199,696
| New | +$9.72M |
|
|
COHR
1298
DELISTED
Coherent Inc
COHR
| $9.61M | 0.01% |
+42,700
| New | +$9.81M |
|
|
ESIO
1299
DELISTED
Electro Scientific Industries
ESIO
| $9.58M | 0.01% |
1,162,100
-79,600
| -6% | -$612K |
|
1300
Peoples Bancorp
PEBO
$1.49B
| $9.56M | 0.01% |
297,700
+24,700
| +9% | +$796K |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.